ZIVO logo

ZIVO Bioscience (ZIVO)

Profile

Full Name

ZIVO Bioscience, Inc.

Ticker Symbol

ZIVO

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

December 15, 2003

Indexes

Not included

Website

http://www.zivobioscience.com

Employees

7

Key Details

Price

$18.80(+5.86%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$157.20K(+467.51% YoY)

Annual EPS

-$4.23(+8.04% YoY)

PE ratio

-

Next earnings date

May 13, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$18.80
ZIVO price is $18.80

30-Day Relative Volume

0.92
ZIVO 30-day relative volume is 0.92

Price Performance

Price Most recent change

+5.86%
ZIVO price was up +5.86% on Apr 25, 2025

Price YTD change

-12.56%
ZIVO price is down -12.56% since January 1st

Price 1-year change

+132.1%
ZIVO price is up +132.1% year-on-year

Price 3-year change

-7.3%
ZIVO price is down -7.3% over the past 3 years

Price Range

Price All-time high

$47.40
ZIVO price is currently -60.34% below its historical high of $47.40

Price 3-year low

$0.48
ZIVO price is currently +3816.67% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$70.67M
ZIVO market capitalization is $70.67 million

Market cap 3-year change

+121.98%
ZIVO market capitalization is up +121.98% over the past 3 years

Market cap All-time high

$80.33M
ZIVO market capitalization is currently -12.02% below its historical high of $80.33 million

Market cap sector rank

41.02%
ZIVO market capitalization is higher than 41.02% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+34.11%
ZIVO shares outstanding is up +34.11% year-on-year

Shares Outstanding 3-Year Change

+139.45%
ZIVO shares outstanding is up +139.45% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

-0.20
ZIVO beta is -0.20

200-day SMA

$16.56
ZIVO price is currently +13.51% above its 200-day simple moving average

50-day SMA

$17.70
ZIVO price is currently +6.20% above its 50-day simple moving average

RSI

59.07
ZIVO 14-day relative strength index is 59.07

Volume

0.92
ZIVO 30-day relative volume is 0.92

ATR

$1.73
ZIVO average true range is $1.73

10-day Historical Volatility

238.68%
ZIVO 10-day historical volatility is 238.68%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$157.20K
ZIVO annual revenue is $157.20 thousand

Revenue Analysts estimate

$987.00K
ZIVO annual revenue is currently -84.07% lower than the consensus analysts' forecast

Revenue 1-year change

+467.51%
ZIVO annual revenue is up +467.51% year-on-year

Revenue Sector rank

5.94%
ZIVO annual revenue is higher than 5.94% of companies in Healthcare sector

EPS

EPS

-$4.23
ZIVO annual earnings per share is -$4.23

EPS Analysts estimate

-
ZIVO annual earnings per share consensus analysts' forecast is unknown

EPS 1-year change

+8.04%
ZIVO annual earnings per share is up +8.04% year-on-year

EPS Sector rank

21.66%
ZIVO annual earnings per share is higher than 21.66% of companies in Healthcare sector

Profit

Gross profit

$49.00K
ZIVO annual gross profit is $49.00 thousand

Gross margin

31.14%
ZIVO annual gross profit margin is 31.14%

Operating profit

-$13.36M
ZIVO annual operating income is -$13.36 million

Operating margin

-8498.85%
ZIVO annual operating profit margin is -8498.85%

Net income

-$13.38M
ZIVO annual net profit is -$13.38 million

Net margin

-8513.44%
ZIVO annual net profit margin is -8513.44%

Expenses

Total expenses

$13.52M
ZIVO annual total expenses is $13.52 million

Operating expenses

$13.41M
ZIVO annual total operating expenses is $13.41 million

Cost of goods sold

$108.30K
ZIVO annual cost of goods sold is $108.30 thousand

Selling, general & administrative expenses

$10.28M
ZIVO annual SGA is $10.28 million

Depreciation and amortization

-
ZIVO annual depreciation & amortization value is unknown

Interest expense

$22.90K
ZIVO annual interest expense is $22.90 thousand

Income tax

-
ZIVO annual income tax value is unknown

EBIT & EBITDA

EBIT

-$13.36M
ZIVO annual earnings before interest & taxes is -$13.36 million

EBITDA

-$13.36M
ZIVO annual EBITDA is -$13.36 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$1.64M
ZIVO annual total assets is $1.64 million

Non current assets

$7700.00
ZIVO annual long term assets is $7700.00

Current assets

$1.64M
ZIVO annual total current assets is $1.64 million

Cash and cash equivalents

$1.54M
ZIVO annual cash & cash equivalents is $1.54 million

Accounts receivable

$2200.00
ZIVO annual accounts receivable is $2200.00

Inventory

-
ZIVO annual inventory value is unknown

Liabilities

Total liabilities

$2.16M
ZIVO annual total liabilities is $2.16 million

Long term liabilities

$116.20K
ZIVO annual total long term liabilities is $116.20 thousand

Current liabilities

$2.04M
ZIVO annual total current liabilities is $2.04 million

Accounts payable

$547.10K
ZIVO annual accounts payable is $547.10 thousand

Debt

Total debt

$254.40K
ZIVO annual total debt is $254.40 thousand

Total debt 1-year change

-26.54%
ZIVO annual total debt is down -26.54% year-on-year

Long term debt

$116.20K
ZIVO annual long term debt is $116.20 thousand

Short term debt

$138.20K
ZIVO annual short term debt is $138.20 thousand

Equity & Capital

Shareholders equity

-$514.90K
ZIVO annual stockholders equity is -$514.90 thousand

Book value

-$514.90K
ZIVO annual book value is -$514.90 thousand

Retained earnings

-$136.97M
ZIVO annual retained earnings is -$136.97 million

Working capital

-$406.40K
ZIVO annual working capital is -$406.40 thousand

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

-$4.31M
ZIVO annual cash flow from operations is -$4.31 million

Cash from operations 1-year change

+25.63%
ZIVO annual cash flow from operations is up +25.63% year-on-year

Cash from investing

$0.00
ZIVO annual cash flow from investing activities is $0.00

Cash from investing 1-year change

0%
ZIVO {parameterFullLabel} has remained unchanged year-on-year

Cash from financing

$5.58M
ZIVO annual cash flow from financing activities is $5.58 million

Cash from financing 1-year change

+30.56%
ZIVO annual cash flow from financing activities is up +30.56% year-on-year

CAPEX

CAPEX

-
ZIVO annual capital expenditures value is unknown

CAPEX 1-year change

-
ZIVO annual capital expenditures 1-year change is unknown

Free Cash Flow

Free cash flow

-$4.31M
ZIVO annual free cash flow is -$4.31 million

Free cash flow 1-year change

+25.63%
ZIVO annual free cash flow is up +25.63% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

31.14%
ZIVO annual gross profit margin is 31.14%

Operating margin

-8498.85%
ZIVO annual operating profit margin is -8498.85%

Net margin

-8513.44%
ZIVO annual net profit margin is -8513.44%

ROA & ROE

ROA

-1217.45%
ZIVO annual return on assets is -1217.45%

ROE

2599.50%
ZIVO annual return on equity is 2599.50%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

-
ZIVO price to earnings ratio value is unknown

PE ratio Sector rank

-
ZIVO price to earnings ratio is unknown

PB Ratio

PB ratio

-137.26
ZIVO price to book ratio is -137.26

PB ratio Sector rank

0.08%
ZIVO price to book ratio is higher than 0.08% of companies in Healthcare sector

PS Ratio

PS ratio

449.57
ZIVO price to sales ratio is 449.57

PS ratio Sector rank

97.42%
ZIVO price to sales ratio is higher than 97.42% of companies in Healthcare sector

Enterprise value

Enterprise value

$69.38M
ZIVO enterprise value is $69.38 million

Enterprise value Sector rank

44.11%
ZIVO enterprise value is higher than 44.11% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

-5.19
ZIVO EV/EBITDA is -5.19

EV/EBITDA Sector rank

19.72%
ZIVO EV/EBITDA is higher than 19.72% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

0.80
ZIVO annual current ratio is 0.80

Quick ratio

-
ZIVO annual quick ratio value is unknown

Leverage

Debt to equity

-0.49
ZIVO annual debt to equity ratio is -0.49

Interest coverage ratio

-583.49
ZIVO annual interest coverage ratio is -583.49

Risk & Stability

Piotroski F-Score

-
ZIVO piotroski f-score value is unknown

Altman Z-Score

-124.09
ZIVO altman z-score is -124.09

Analyst ratings

Recent major analysts updates

Jun 4, 24 Maxim Group
Hold
Dec 15, 21 Maxim Group
Buy

Institutional Ownership

Similar stocks

CCLD logo
CareCloud (CCLD)
YI logo
111 (YI)
XTNT logo
Xtant Medical Holdings (XTNT)
ICCM logo
IceCure Medical Ltd (ICCM)
JSPR logo
Jasper Therapeutics (JSPR)
DOMH logo
Dominari Holdings (DOMH)
INCR logo
InterCure (INCR)
CPIX logo
Cumberland Pharmaceuticals (CPIX)
CRBU logo
Caribou Biosciences (CRBU)
  • What is the ticker symbol for ZIVO Bioscience?
  • Does ZIVO Bioscience pay dividends?
  • What sector is ZIVO Bioscience in?
  • What industry is ZIVO Bioscience in?
  • What country is ZIVO Bioscience based in?
  • When did ZIVO Bioscience go public?
  • Is ZIVO Bioscience in the S&P 500?
  • Is ZIVO Bioscience in the NASDAQ 100?
  • Is ZIVO Bioscience in the Dow Jones?
  • When was ZIVO Bioscience's last earnings report?
  • When does ZIVO Bioscience report earnings?
  • Should I buy ZIVO Bioscience stock now?

What is the ticker symbol for ZIVO Bioscience?

The ticker symbol for ZIVO Bioscience is NASDAQ:ZIVO

Does ZIVO Bioscience pay dividends?

No, ZIVO Bioscience does not pay dividends

What sector is ZIVO Bioscience in?

ZIVO Bioscience is in the Healthcare sector

What industry is ZIVO Bioscience in?

ZIVO Bioscience is in the Biotechnology industry

What country is ZIVO Bioscience based in?

ZIVO Bioscience is headquartered in United States

When did ZIVO Bioscience go public?

ZIVO Bioscience's initial public offering (IPO) was on December 15, 2003

Is ZIVO Bioscience in the S&P 500?

No, ZIVO Bioscience is not included in the S&P 500 index

Is ZIVO Bioscience in the NASDAQ 100?

No, ZIVO Bioscience is not included in the NASDAQ 100 index

Is ZIVO Bioscience in the Dow Jones?

No, ZIVO Bioscience is not included in the Dow Jones index

When was ZIVO Bioscience's last earnings report?

ZIVO Bioscience's most recent earnings report was on Nov 14, 2024

When does ZIVO Bioscience report earnings?

The next expected earnings date for ZIVO Bioscience is May 13, 2025

Should I buy ZIVO Bioscience stock now?

As of today, analysts generally recommend a 'Hold' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page